Call for comments: WHO preferred product characteristics for therapeutic HPV vaccines

Deadline for submission of comments: 6 October 2023

https://www.who.int/news-room/articles-detail/call-for-comments-who-preferred-product-characteristics-for-therapeutic-hpv-vaccines

Document: https://cdn.who.int/media/docs/default-source/reproductive-health/cervical-cancer/who-ppc-therapeutic-hpv-vaccines-public-comment.pdf

Comment form: https://cdn.who.int/media/docs/default-source/reproductive-health/cervical-cancer/comment-form-ppc-therapeutic-hpv-vx.docx

This draft document is being posted for the purpose of inviting public comments and suggestions on the content contained herein, before the document will be considered by WHO's Product Development for Vaccines Advisory Committee (PDVAC) for endorsement.

Written comments proposing modifications to this text must be received by 6 October 2023 and entered in the Comment Form below and should be addressed to Dr Holly Prudden at pruddenh@who.int with the subject line “Comment: WHO PPCs for therapeutic HPV vaccines”.